HCW

Latest SEC Filings & News for HCW

2 most recent filings and news items mentioning HCW. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/HCW/news?limit=20"

Pull HCW filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RestructuringJun 26, 2026Neutral

HCW Biologics adopts 1-for-6 reverse stock split

HCW Biologics implemented a 1-for-6 reverse stock split effective June 30, 2026. This corporate action aims to increase the share price to meet listing requirements and enhance marketability.

View filing at SEC.gov →

OfferingMay 21, 2026Neutral

HCW Biologics issues pre-funded warrant agreement for common stock purchase

HCW Biologics Inc. filed a pre-funded warrant form allowing holders to purchase common shares at a specified exercise price beginning in 2026. The warrant issuance represents a capital raising mechanism typically used in equity financings for growth-stage biotech companies.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.